224 related articles for article (PubMed ID: 28918668)
1. Current status and future prospects for the development of substance abuse vaccines.
Heekin RD; Shorter D; Kosten TR
Expert Rev Vaccines; 2017 Nov; 16(11):1067-1077. PubMed ID: 28918668
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic strategies for treating opioid use disorder and overdose.
Luba R; Martinez S; Jones J; Pravetoni M; Comer SD
Expert Opin Investig Drugs; 2023 Jan; 32(1):77-87. PubMed ID: 36696567
[TBL] [Abstract][Full Text] [Related]
3. Animal Models and the Development of Vaccines to Treat Substance Use Disorders.
Ohia-Nwoko O; Kosten TA; Haile CN
Int Rev Neurobiol; 2016; 126():263-91. PubMed ID: 27055616
[TBL] [Abstract][Full Text] [Related]
4. Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidates.
Ntege EH; Takashima E; Morita M; Nagaoka H; Ishino T; Tsuboi T
Expert Rev Vaccines; 2017 Aug; 16(8):769-779. PubMed ID: 28604122
[TBL] [Abstract][Full Text] [Related]
5. Current status of vaccines for substance use disorders: A brief review of human studies.
Truong TT; Kosten TR
J Neurol Sci; 2022 Mar; 434():120098. PubMed ID: 34952345
[TBL] [Abstract][Full Text] [Related]
6. Anti-drug vaccines to treat substance abuse.
Kinsey BM; Jackson DC; Orson FM
Immunol Cell Biol; 2009; 87(4):309-14. PubMed ID: 19333250
[TBL] [Abstract][Full Text] [Related]
7. Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence.
Carfora A; Cassandro P; Feola A; La Sala F; Petrella R; Borriello R
J Bioeth Inq; 2018 Mar; 15(1):45-55. PubMed ID: 29350320
[TBL] [Abstract][Full Text] [Related]
8. Substance abuse vaccines.
Orson FM; Kinsey BM; Singh RA; Wu Y; Gardner T; Kosten TR
Ann N Y Acad Sci; 2008 Oct; 1141():257-69. PubMed ID: 18991962
[TBL] [Abstract][Full Text] [Related]
9. Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine.
Soyka M; Mutschler J
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():148-61. PubMed ID: 26577297
[TBL] [Abstract][Full Text] [Related]
10. Substance use in pregnancy.
Wong S; Ordean A; Kahan M; ; ; ; ;
J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for Substance Use Disorders.
Klein JW
Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
[TBL] [Abstract][Full Text] [Related]
12. Management of comorbid bipolar disorder and substance use disorders.
Salloum IM; Brown ES
Am J Drug Alcohol Abuse; 2017 Jul; 43(4):366-376. PubMed ID: 28301219
[TBL] [Abstract][Full Text] [Related]
13. Vaccines as Immunotherapies for Substance Use Disorders.
Kosten TR
Am J Psychiatry; 2024 May; 181(5):362-371. PubMed ID: 38706331
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Treatment of Youth Substance Use Disorders.
Squeglia LM; Fadus MC; McClure EA; Tomko RL; Gray KM
J Child Adolesc Psychopharmacol; 2019 Aug; 29(7):559-572. PubMed ID: 31009234
[TBL] [Abstract][Full Text] [Related]
15. The path forward.
De Gregorio E
Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
[TBL] [Abstract][Full Text] [Related]
16. Medications for substance use disorders (SUD): emerging approaches.
Butelman ER; Kreek MJ
Expert Opin Emerg Drugs; 2017 Dec; 22(4):301-315. PubMed ID: 29057665
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic vaccines for substance dependence.
Haney M; Kosten TR
Expert Rev Vaccines; 2004 Feb; 3(1):11-8. PubMed ID: 14761239
[TBL] [Abstract][Full Text] [Related]
18. Conjugate Vaccine Immunotherapy for Substance Use Disorder.
Bremer PT; Janda KD
Pharmacol Rev; 2017 Jul; 69(3):298-315. PubMed ID: 28634286
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapies for the Treatment of Drug Addiction.
Hossain MK; Davidson M; Kypreos E; Feehan J; Muir JA; Nurgali K; Apostolopoulos V
Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366287
[TBL] [Abstract][Full Text] [Related]
20. Discussing prevalence, impacts, and treatment of substance use disorders in athletes.
Gil F; de Andrade AG; Castaldelli-Maia JM
Int Rev Psychiatry; 2016 Dec; 28(6):572-578. PubMed ID: 27534440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
